Research Interests
critical/intensive care medici
,
health services, research/outc
,
surgery/trauma/burns/trauma
Recent Publications
Morris P, Zeno B, Bernard A, Huang X, Simonson S, Bernard G.
Safety and tolerability of an ovine-derived polyclonal anti-TNFalpha Fab fragment (AZD9773) in patients with severe sepsis [abstract]. Crit Care.
2011;
15(Suppl 1):S93.
Morris PE, Griffin L, Berry M, Thompson C, Hite RD, Winkelman C, Ross A, Dixon L, Leach S, Haponik E, et al.
Receiving early mobility during an intensive care unit admission is a predictor of improved outcomes in acute respiratory failure. Am J Med Sci.
2011;
341(5):373-377.
Crawford J, Guntupalli KK, Dean NC, Morris PE, Malik RK, Schaunberg JP.
Talactoferrin alfa (TLF) reduces mortality across a broad range of patients with severe sepsis [abstract]. J Thorac Oncol.
2011;
6(6 Suppl 2):S1487.
Hite RD, Seeds MC, Morris PE, Grier BL, Waite BM, Douglas IS, Hudson LD, Goodman RB.
Regulation of secretory A2 phospholipase activity in persistent ARDS [abstract]. Am J Respir Crit Care Med.
2010;
181():A6474.
Guntupalli KK, Dean NC, Morris PE, Bandi V, Margolis BD, Rivers E, Levy MM, Lodato RF, Schaumberg J, Malik RK, et al.
Talactoferrin alfa reduces mortality in severe sepsis: results of a phase 2 randomized, placebo-controlled, double-blind study [abstract]. Am J Respir Crit Care Med.
2010;
181(1 Meeting Abstracts):A6768.
Morris PE, Promes JT, Guntupalli KK, Wright PE, Arons MM.
A multi-center, randomized, double-blind, parallel, placebo-controlled trial to evaluate the efficacy, safety, and pharmacokinetics of intravenous ibuprofen for the treatment of fever in critically ill and non-critically ill adults. Crit Care.
2010;
14(3):R125.
Lanspa M, Brown S, Grissom C, Morris P, Malik R, Pittman J, Dean N.
Talactoferrin may confer increased survival in patients with septic shock and systolic cardiac dysfunction [abstract]. Crit Care Med.
2010;
38(12 Suppl):Abstr 757.
Levy M, Guntupalli K, Dellinger R, Dean N, Morris P, Bandi V, Margolis B, Rivers E, Lodato R, Schaumberg J.
Talactoferrin alfa reduces 3 and 6 month all-cause mortality in patients with severe sepsis [abstract]. Crit Care Med.
2010;
38(12 Suppl):abstr 26.
Morris PE, Goad A, Thompson C, Taylor K, Harry B, Passmore L, Ross A, Howard A, Hite RD, Haponik E, et al.
Early intensive care unit mobility therapy in the treatment of acute respiratory failure. Crit Care Med.
2008;
36(8):2238-2243.
Morris PE.
Preface. Crit Care Clin.
2007;
23(1):ix-xi.
Updaw R, Passmore L, Mitten-Long D, Pierce C, Ross A, Wells G, Morris P.
Fluid resuscitation volume for septic shock patients was not decreased for echocardiogram-determined left ventricular (LV) systolic dysfunction patients when managed with early goal-directed therapy (EGDT) [abstract]. Chest.
2007;
132(4 Suppl):495S.
Daniel A, Owen S, Ross A, Brown J, Ashley A, Bozeman W, Karchmer T, Williamson J, Passmore L, Morris PE, et al.
A multi-department strategy for severe sepsis patient resuscitation [abstract]. Crit Care Med.
2006;
34(12 Abstr Suppl):A143.
Morris PE, Holbrook A, Thompson C, Ross A, Anderson L, Baker S, Penley L, Daniel A, Howard A, Passmore L, et al.
A mobility protocol for acute respiratory failure patients delivered by an ICU mobility team shortens hospital stay [abstract]. Crit Care Med.
2006;
34(12 Abstr Suppl):A20.
All Publications
For a listing of recent publications, refer to PubMed, a service provided by the National Library of Medicine.
For a list of earlier publications, visit the Carpenter Library Publication Search.